Long-term safety and durability of effect of ecopipam in pediatric patients with Tourette Syndrome: Results of a 12-month open-label extension (OLE) study

被引：0
|
作者：
Gilbert, D.
Kim, D.
Miller, M.
Horine, S.
Saljooqi, K.
Karkanias, G.
Wanaski, S.
Cunniff, T.
机构：
来源：
ANNALS OF NEUROLOGY | 2023年 / 94卷
关键词：
Movement Disorders;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
149
引用
收藏
页码：S85 / S85
页数：1
相关论文
共 50 条
  • [41] Frovatriptan for the prevention of menstrual migraine headaches: Results of a 12-month open-label safety and tolerability study
    Gammaitoni, A
    Ford, C
    Tobin, J
    Shaw, R
    Campbell, J
    NEUROLOGY, 2006, 66 (05) : A224 - A224
  • [42] Add-on cannabidiol in patients with Dravet syndrome: Results of a long-term open-label extension trial
    Scheffer, Ingrid E.
    Halford, Jonathan J.
    Miller, Ian
    Nabbout, Rima
    Sanchez-Carpintero, Rocio
    Shiloh-Malawsky, Yael
    Wong, Matthew
    Zolnowska, Marta
    Checketts, Daniel
    Dunayevich, Eduardo
    Devinsky, Orrin
    EPILEPSIA, 2021, 62 (10) : 2505 - 2517
  • [43] Long-term efficacy and safety of elamipretide in patients with Barth syndrome: 168-week open-label extension results of TAZPOWER
    Thompson, William R.
    Manuel, Ryan
    Abbruscato, Anthony
    Carr, Jim
    Campbell, John
    Hornby, Brittany
    Vaz, Frederic M.
    Vernon, Hilary J.
    GENETICS IN MEDICINE, 2024, 26 (07)
  • [44] A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults
    Richards, Cynthia
    Iosifescu, Dan V.
    Mago, Rajnish
    Sarkis, Elias
    Geibel, Brooke
    Dauphin, Matthew
    McIntyre, Roger S.
    Weisler, Richard
    Brawman-Mintzer, Olga
    Gu, Joan
    Madhoo, Manisha
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2018, 38 (04) : 336 - 343
  • [45] Safety and efficacy of calcium hydroxylapatite dermal filler for hand treatment: A 12-month open-label extension study
    Goldman, Mitchel
    Moradi, Amir
    Katz, Bruce
    Gold, Michael
    Alizadeh, Kaveh
    Adelglass, Jeffrey
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB20 - AB20
  • [46] Laboratory safety of long-term dupilumab treatment in adults with moderate-to-severe atopic dermatitis: Results from an open-label extension (OLE) study
    Blauvelt, Andrew
    Wollenberg, Andreas
    Beck, Lisa A.
    Chen, Zhen
    Zhang, Meng
    Khokhar, Faisal A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB142 - AB142
  • [47] Maintenance of Long-Term Safety and Efficacy of Cannabidiol (CBD) Treatment in Dravet Syndrome (DS): Results of the Open-Label Extension (OLE) Trial (GWPCARE5)
    Miller, Ian
    Devinsky, Orrin
    Nabbout, Rima
    Laux, Linda
    Zolnowska, Marta
    Wright, Stephen
    Roberts, Claire
    NEUROLOGY, 2018, 90
  • [48] Long-Term Safety, Tolerability, and Durability of Treatment Effect of Olanzapine and Samidorphan: Results of a 4-Year Open-Label Study
    Ballon, Jacob S.
    Kahn, Rene S.
    Arevalo, Christina
    Dunbar, Martin
    Mcdonnell, David
    Correll, Christoph U.
    JOURNAL OF CLINICAL PSYCHIATRY, 2025, 86 (01)
  • [49] Maintenance of Long-Term Safety and Efficacy of Cannabidiol (CBD) Treatment in Dravet Syndrome (DS): Results of the Open-Label Extension (OLE) Trial (GWPCARE5)
    Laux, L.
    Devinsky, O.
    Miller, I
    Nabbout, R.
    Zolnowska, M.
    Wright, S.
    Roberts, C.
    ANNALS OF NEUROLOGY, 2018, 84 : S344 - S344
  • [50] Long-term use of solifenacin in pediatric patients with overactive bladder: Extension of a prospective open-label study
    Nadeau, Genevieve
    Schroeder, Annette
    Moore, Katherine
    Genois, Lucie
    Lamontagne, Pascale
    Hamel, Micheline
    Pellerin, Eve
    Bolduc, Stephane
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2014, 8 (3-4): : 118 - 123
12345